Evidence map›Paper›PMID 37071399›Full record

ArticleVector borne and zoonotic diseases (Larchmont, N.Y.)2023

Incidence of Lyme Borreliosis in Germany: Exploring Observed Trends Over Time Using Public Surveillance Data, 2016-2020.

Jozica Skufca, Thao Mai Phuong Tran, Gordon Brestrich, Andreas Pilz, Andrew Vyse, Claudius Malerczyk, Mendwas Dzingina, Elizabeth Begier, Maxim Blum, Margarita Riera-Montes and 2 more

Abstract read
In one paragraph

Article in Vector borne and zoonotic diseases (Larchmont, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Lyme borreliosis.Nature reviews. Disease primers · 2026
    Review
  4. Article
  5. Serological Assessment ofPathogens (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jozica SkufcaEpidemiology & Pharmacovigilance, P95, Leuven, Belgium.
Thao Mai Phuong TranEpidemiology & Pharmacovigilance, P95, Leuven, Belgium.
Gordon BrestrichPfizer Pharma GmbH, Berlin, Germany.
Andreas PilzPfizer Global Medical Affairs, Vaccines, Vienna, Austria.
Andrew VyseVaccines Medical Affairs, Pfizer Ltd., Walton Oaks, United Kingdom.
Claudius MalerczykPfizer Pharma GmbH, Berlin, Germany.
Mendwas DzinginaPatient Health and Impact, Chief Business Office, Pfizer Inc, New York, New York, USA.
Elizabeth BegierVaccine Clinical Research and Development, Pfizer Inc, Pearl River, New York, New York, USA.
Maxim BlumEpidemiology & Pharmacovigilance, P95, Leuven, Belgium.
Margarita Riera-MontesEpidemiology & Pharmacovigilance, P95, Leuven, Belgium.
Bradford D GessnerVaccines Medical Development & Scientific/Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA.
James H StarkVaccines Medical Development & Scientific/Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA.ORCID 0000-0002-0728-876X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lyme DiseaseAnimalsGermanyIncidenceSeasonsGermanyincidenceLyme borreliosisspatial epidemiologysurveillancetick-borne disease

Identifiers

PMID37071399
PMCPMC10122258

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.